Engineered bacterial protein exposes systemic gaps in cancer treatment: How soil-derived toxins reveal failures in mitochondrial-targeted therapies and industrial agriculture

Indigenous cosmologies universally treat soil as a sentient, interconnected entity whose health reflects human actions; the bacterial protein’s extraction and engineering violate the principle of reciprocity central to these worldviews. Traditional healers in regions like the Amazon or Himalayas use soil-derived remedies (e.g., *chanca piedra* or *shilajit*) but within frameworks of ecological balance and spiritual intention, unlike the extractive, profit-driven approach of Western science. The omission of these perspectives in the study reflects a colonial legacy where indigenous knowledge is either appropriated or dismissed, despite its proven efficacy in maintaining health.

The modern crisis of colorectal cancer is historically linked to the Green Revolution’s disruption of soil microbiomes through synthetic fertilizers and pesticides, which began in the mid-20th century and accelerated global soil degradation. Prior to industrial agriculture, colorectal cancer was rare; its rise parallels the decline of traditional farming systems and the introduction of processed foods. The study’s focus on mitochondrial targeting echoes past biomedical paradigms, such as the mid-20th century push for chemotherapy, which similarly treated symptoms while ignoring root causes like environmental toxins and dietary shifts.

In Traditional Chinese Medicine (TCM), colorectal health is tied to the balance of *Qi* and the integrity of the *Spleen* and *Stomach* meridians, with treatments emphasizing dietary therapy and herbal medicine to restore harmony. African traditional medicine systems, such as those in Nigeria or South Africa, use soil-derived clays and fermented botanicals to treat digestive disorders, often with fewer side effects than synthetic drugs. The Western biomedical model’s reductionism contrasts sharply with these holistic approaches, which view the body as an ecosystem rather than a machine to be repaired.

The study’s methodology—engineering a bacterial protein to target mitochondrial dysfunction—aligns with emerging evidence that soil microbiomes produce bioactive compounds with therapeutic potential, including anticancer properties. However, the research isolates this protein from its ecological context, ignoring how soil degradation (e.g., loss of mycorrhizal fungi) may have contributed to the rise of colorectal cancer in the first place. Long-term clinical trials are needed to assess the protein’s safety and efficacy, particularly given the risk of off-target effects in human cells.

Artistic traditions often symbolize cancer as a 'wild growth' disrupting harmony, reflecting the ecological imbalance the bacterial protein exploits; for example, in Japanese *sumi-e* paintings, tumors are depicted as invasive, unbalanced forms. Spiritual practices, such as Ayurveda or Tibetan medicine, frame disease as a disruption in *prana* or *lung*, often tied to environmental toxins and emotional disharmony—concepts absent in the study’s framing. The bacterial protein’s mechanism (disrupting mitochondrial function) mirrors the 'cellular chaos' described in mystical traditions as a loss of divine order within the body.

If scaled, this technology could reduce colorectal cancer mortality but may exacerbate soil microbiome depletion by incentivizing further extraction of bacterial proteins, creating a feedback loop of ecological harm. Alternative futures include agroecological systems that restore soil health, reducing cancer risks while eliminating the need for such interventions. Policymakers must weigh the short-term benefits of pharmaceutical innovations against the long-term costs of ecological degradation and the loss of traditional knowledge systems.

Smallholder farmers in regions like Sub-Saharan Africa or South Asia, who bear the brunt of soil degradation, are rarely consulted in biomedical research despite their intimate knowledge of soil health and local ecosystems. Indigenous communities, whose lands are often targeted for bioprospecting (e.g., the patenting of neem or turmeric), are systematically excluded from decision-making about how their knowledge is used. Patients in low-income countries, who lack access to expensive pharmaceuticals, are also sidelined in discussions about 'solutions,' despite bearing the highest burden of colorectal cancer.